Why the study?
Do anticholinergic drugs with neostigmine impair parasympathetic control of heart rate in ASA I-II patients undergoing minor surgery?
RCT (n=30)
Double-blind
Do anticholinergic drugs with neostigmine impair parasympathetic control of heart rate in ASA I-II patients undergoing minor surgery?
Atropine with neostigmine causes prolonged impairment of parasympathetic control of heart rate in the early postoperative period, whereas glycopyrrolate has a shorter duration of effect.
Answers are grounded in this paper and cite their sources.
Impairment of parasympathetic control persists after anticholinergic-neostigmine reversal; supports caution in high-risk patients and targeted trials in larger cohorts.
Impaired parasympathetic control of heart rate is associated with increased incidence of cardiac dysrhythmias and ischemia.Anticholinergic drugs suppress parasympathetic control and could be detrimental in the early postoperative period in high-risk patients. In this double-blind randomized trial, 30 ASA physical status I and II patients undergoing minor surgery received either atropine 20 micro g/kg and neostigmine 50 micro g/kg (Group A), glycopyrrolate 8 micro g/kg and neostigmine 50 micro g/kg (Group G), or placebo (Group P) for reversal of neuromuscular blockade. Two indices of parasympathetic modulation of heart rate, spontaneous baroreflex sensitivity, and high-frequency heart rate variability, were assessed. At 2 h after reversal, Group A showed persisting impairment of baroreflex sensitivity with respect to Group P (7.12 +/- 0.86 vs 12.71 +/- 1.38 ms/mm Hg, P = 0.022) as well as decreased high-frequency heart rate variability (280.8 +/- 30.1 vs 569.2 +/- 115.2 ms2/Hz, P = 0.015). Groups A and G showed a borderline decrease in normalized high-frequency variability at 2 h (P = 0.05 for Groups A and G versus Group P). Anticholinergic drugs with neostigmine cause impairment of parasympathetic control of heart rate which persists into the early postoperative period. The effects of glycopyrrolate appear to be of shorter duration; this drug may thus be preferable in patients at risk of cardiovascular complications. (Anesth Analg 1997;84:148-54)
No takes yet. Share an insight, caveat, or question.
Vlymen et al. (1997) conducted an RCT in Minor surgery (n=30). Atropine and neostigmine or glycopyrrolate and neostigmine vs. Placebo was evaluated on Spontaneous baroreflex sensitivity (p=0.022).
Synapse has enriched 10 related papers. Consider them for comparative context: